Compare CORT & STAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | STAG |
|---|---|---|
| Founded | 1998 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 7.9B |
| IPO Year | 2001 | 2010 |
| Metric | CORT | STAG |
|---|---|---|
| Price | $95.41 | $41.11 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 9 |
| Target Price | ★ $96.50 | $39.67 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $761,407,000.00 | ★ $845,184,000.00 |
| Revenue This Year | $26.08 | $8.59 |
| Revenue Next Year | $26.98 | $9.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.79 | 10.14 |
| 52 Week Low | $28.66 | $33.72 |
| 52 Week High | $97.05 | $42.61 |
| Indicator | CORT | STAG |
|---|---|---|
| Relative Strength Index (RSI) | 63.30 | 61.54 |
| Support Level | $76.41 | $36.62 |
| Resistance Level | N/A | $42.61 |
| Average True Range (ATR) | 4.17 | 0.78 |
| MACD | -0.36 | 0.12 |
| Stochastic Oscillator | 81.02 | 66.06 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Stag Industrial Inc is a REIT focused on the acquisition, ownership, development, and operation of industrial properties throughout the United States. Its platform is designed to (i) identify properties for acquisition that offer attractive returns across CBRE-EA Tier 1 industrial real estate markets, industries, and tenants, (ii) provide growth through the ownership of high-quality assets, property management and pursuit of acquisitions in an attractive opportunity set, and (iii) capitalize its business appropriately given the characteristics of its assets. The majority of its portfolio is single-tenant industrial properties throughout the United States. The company derives the majority of its rental revenue from its facilities located in Midwestern and Eastern U.S. cities.